// App-Quantinova.ai

319 : Dalcetrapib-Mediated Modulation of Cholesteryl Ester Transfer Protein Activity Increases HDL-Cholesterol, Apolipoprotein A-I Levels and Cholesterol Efflux Capacity in Chow-Fed Rabbits

Researchers

Presenter

  • David Rhainds

Principal Investigators

  • Daniel Charpentier

  • Teodora Mihalache-Avram

  • Cyrille Maugeais

  • Eric Rheaume

  • Eric J Niesor

  • Jean-Claude Tardif

Medical Centers

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Apolipoprotein A-I

  • Nucleoside diphosphate kinase A

  • Malondialdehyde

Drug/Treatment

  • Dalcetrapib

  • Mecasermin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved